Investor Calendar Invites You to the Bovie Medical Corporation Second Quarter 2016 Earnings Conference Call and Webcast Live on Monday, August 1, 2016

CLEARWATER, FL / ACCESSWIRE / August 1, 2016 / Bovie Medical (NYSE MKT: BVX) will host a conference call and live webcast to discuss the results of the second quarter 2016, to be held Monday, August 1, 2016 at 4:30 PM Eastern Time.

To participate in this event, dial 866-932-0173 domestically, or 785-424-1630 internationally, approximately 5 to 10 minutes before the beginning of the call. Additionally, you can listen to the event online at www.investorcalendar.com/IC/CEPage.asp?ID=175164 or on the Bovie Medical website (www.boviemed.com).

If you are unable to participate during the live webcast, the event archive will be available at www.investorcalendar.com or www.boviemed.com.

You may access the teleconference replay by dialing 877-481-4010 domestically or 919-882-2331 internationally, referencing conference ID # 10055. The replay will be available beginning approximately 2 hours after the completion of the live event, ending at midnight Eastern on September 1, 2016.

About Bovie Medical Corporation

Bovie Medical Corporation is a leading maker of medical devices and supplies as well as the developer of J-Plasma®, a patented new plasma-based surgical product for cutting and coagulation. J-Plasma® utilizes a helium ionization process to produce a stable, focused beam of ionized gas that provides surgeons with greater precision, minimal invasiveness and an absence of conductive currents through the patient during surgery. Bovie Medical Corporation is also a leader in the manufacture of a range of electrosurgical products and technologies, marketed through both private labels and the Company’s own well-respected brands (Bovie®, Aaron®, IDS™ and ICON™) to distributors worldwide. The Company also leverages its expertise through original equipment manufacturing (OEM) agreements with other medical device manufacturers. For further information about the Company’s current and new products, please refer to the Investor Relations section of Bovie Medical Corporation’s www.boviemed.com.

SOURCE: Investor Calendar

ReleaseID: 443031